PHYSIOLOGY AND PATHOPHYSIOLOGY OF GROWTH HORMONE VARIANT

生长激素变异体的生理学和病理生理学

• 批准号: 6326895
• 负责人: SUSAN E KIRK
• 金额: $ 11.16万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-08-01 至 2004-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6326895
• 关键词: biological signal transduction; blood vessel disorder; embryo /fetus; genetically modified animals; glomerulosclerosis; growth /development; hormone receptor; hormone regulation /control mechanism; human genetic material tag; insulin dependent diabetes mellitus; insulinlike growth factor; kidney function; laboratory mouse; laboratory rat; pathology; phosphotransferases; physiology; pituitary gland; placental hormones; postdoctoral investigator; pregnancy; secretion; somatomammotropin; somatotropin; tissue /cell culture

DESCRIPTION (provided by applicant): Candidate and Environment: Susan E. Kirk, M.D. is a well-trained clinician whose application for a Mentored Clinical Scientist Development Award will provide the opportunity for her to expand her clinical and basic science research skills. Currently, she is an Assistant Professor in Internal Medicine at the University of Virginia. In addition to her own laboratory, Dr. Kirk has the support and use of the laboratories of Dr. Eugene Barrett (Director, Diabetes Education Research Center) and Dr. Michael Thorner (Chair, Department of Medicine). In addition, the University of Virginia maintains an excellent, state-of-the-art General Clinical Research Center for completion of clinical studies. Background: During Pregnancy, the normal placenta produces multiple hormones including human chorionic somatomammotropin (hCS, formerly termed human placental lactogen or hPL) and another member of the growth hormone gene family -- placental growth hormone variant or GH-V. Because hCS circulates at high concentrations and has approximately 85 percent homology to pituitary growth hormone (GH), many of the GH-like biologic effects seen with pregnant Type I diabetic woman (worsening of microvascular disease), are attributed to the GH- like properties of hCS. The major hypothesis of this proposal is the GH-V, not hCS, is the principal somatotropic agent present in normal pregnancy. It, like pituitary GH, can a) influence pituitary secretion, b) stimulate GH receptor signaling, c) accelerate microvascular changes of diabetes, and d) may play a role in determining intrauterine growth in normal pregnancy and pregnancy complicated by diabetes mellitus. Research Plan: will measure 1) the impact of GH-V on pituitary GH secretion in rats; 2) signal transduction pathways activated by GH-V; 3) the effect of GH-V on glomerular structure in mice.

描述（由申请人提供）：候选人和环境： Susan E.柯克医学博士是一位训练有素的临床医生， 指导临床科学家发展奖将提供机会， 她扩大她的临床和基础科学研究技能。 目前她 是弗吉尼亚大学内科学助理教授。 除了她自己的实验室，柯克博士还得到了 尤金巴雷特博士的实验室（主任，糖尿病教育研究 Michael Thorner博士（医学系主任）。 此外，本发明还提供了一种方法， 弗吉尼亚大学有一个优秀的，最先进的将军 完成临床研究的临床研究中心。 背景资料： 在怀孕期间，正常的胎盘产生多种激素，包括 人绒毛膜生长催乳素（hCS，以前称为人胎盘 催乳素或hPL）和生长激素基因家族的另一个成员-- 胎盘生长激素变体或GH-V。由于hCS以高水平循环， 浓度，并且与垂体生长具有大约85%的同源性， 激素（GH），许多GH样生物效应与妊娠I型 糖尿病女性（微血管疾病恶化），归因于GH- 类似于hCS的性质。该提案的主要假设是GH-V，而不是 hCS是存在于正常妊娠中的主要促生长剂。 它， 与垂体GH一样，可以a）影响垂体分泌，B）刺激GH c）加速糖尿病的微血管变化，和 d）可能在正常妊娠中决定子宫内生长方面起作用， 妊娠合并糖尿病。 研究计划：将衡量 1)GH-V对大鼠垂体GH分泌的影响; 2)GH-V激活的信号转导通路; 3）GH-V对 小鼠肾小球结构。